Cryoablation of bone metastases in thyroid and adrenocortical cancers
Endocrine-Related Cancer · 2026
DOI: 10.1530/erc-25-0306 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Endocrine-Related Cancer, 2026. Verfasst von Ricardo Miguel Costa de Freitas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Interventional Radiology Unit, Instituto de Radiologia, Hospital das Clínicas, Universidade de São Paulo Medical School, São Paulo, SP, Brazil. Hauptthemen laut MEDLINE: Adrenal Cortex Neoplasms, Bone Neoplasms, Cryosurgery, Thyroid Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
The purpose of this study is to assess the feasibility, efficacy and safety of cone-beam computed tomography (CBCT)-guided cryoablation of bone metastases in thyroid and adrenocortical cancers. Adult patients with bone metastases and at least 1 skeletal-related event (pain, risk of fracture, spinal cord compression or hypercalcemia) at baseline were enrolled in a prospective, single-arm, single-center IRB-approved study (ClinicalTrials: NCT03986593). Brief Pain Inventory – Short Form (BPI-SF) and morphine-equivalent daily dose (M-EDD) were recorded at baseline and weekly during the first 8 weeks and 3, 6, 12 and 24 months post-cryoablation. Adverse events (AEs) and pre- and post-treatment cross-sectional (CT or MR) and functional imaging with PET/CT were analyzed. Seventeen patients (mean age of 58.3 ± 16.2 years old; 11 women) with either differentiated (n = 8; 47.1%) or medullary thyroid cancer (n = 6; 35.6%), or adrenocortical cancer (n = 3; 17.3%) were enrolled. CBCT-guided cryoablation of 24 bone metastases reached 100% technical success rate. An overall drop of 4.8 points (P < 0.05) in the worst pain in the last 24 h and M-EDD overall intake decrease (P < 0.05) were observed. In addition to pain improvement, no patients required surgery. Three patients (17.6%) required radiotherapy due to refractory or recurrent pain over a follow-up of 14.9 ± 14.0 (median ± IQR) months. No grade 4 or 5 AE was reported. One grade 3 AE (5.9%) and two grade 2 AEs (11.8%) occurred. PET/CT imaging showed a 52% reduction in FDG uptake immediately after cryoablation. Cryoablation of bone metastases in thyroid and adrenocortical cancers was safe and effective, providing rapid and long-lasting pain relief and improving quality of life. ClinicalTrials.gov: NCT 03986593. Clinical relevance statements Cryoablation led to a sustained reduction in pain with a mean improvement of 7.2 points on a 1–10 scale of the Brief Pain Inventory – Short Form (BPI-SF) after 54 weeks. Pain relief and quality-of-life improvement (assessed by the BPI-SF) were observed in 81.3% of bone metastases just one week after cryoablation with an overall pain score reduction of 4.8 points. Cryoablation of bone metastases from endocrine cancers was safe and effective, providing long-lasting pain relief.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interventional Radiology Unit, Instituto de Radiologia, Hospital das Clínicas, Universidade de São Paulo Medical School, São Paulo, SP, Brazil.
- Radiology Unit, Instituto do Cancer do Estado de São Paulo, Universidade de São Paulo Medical School, São Paulo, SP, Brazil.
- Endocrinology Unit, Instituto do Cancer do Estado de São Paulo, Universidade de São Paulo Medical School, São Paulo, SP, Brazil.
- Anesthesiology Unit, Instituto do Cancer do Estado de São Paulo, Universidade de São Paulo Medical School, São Paulo, SP, Brazil.
- Bioestatistics Institute, Universidade do Estado de São Paulo - Botucatu, Botucatu, SP, Brazil.
- Nuclear Medicine Unit, Instituto de Radiologia, Hospital Das Clínicas, Universidade de São Paulo Medical School, São Paulo, SP, Brazil.
ORCID-Profile: Ricardo Miguel Costa de Freitas, Debora Lucia Seguro Danilovic
Zitieren
APA
de Freitas, R. M. C., Hoff, A. O., Fragoso, M. C. B. V., Sousa, A. M., Danilovic, D. L. S., de Castroneves, L. A., Grigio, T. R., Tsunemi, M. H., Buchpiguel, C. A., & Caldas, J. G. M. P. (2026). Cryoablation of bone metastases in thyroid and adrenocortical cancers. Endocrine-Related Cancer. https://doi.org/10.1530/erc-25-0306
Vancouver
de Freitas RMC, Hoff AO, Fragoso MCBV, Sousa AM, Danilovic DLS, de Castroneves LA, et al. Cryoablation of bone metastases in thyroid and adrenocortical cancers. Endocrine-Related Cancer. 2026. doi:10.1530/erc-25-0306
BibTeX
@article{deFreitas2026,
author = {de Freitas, Ricardo Miguel Costa and Hoff, Ana Oliveira and Fragoso, Maria Candida Barisson Villares and Sousa, Angela Maria and Danilovic, Debora Lucia Seguro and de Castroneves, Luciana Audi and Grigio, Thiago Ramos and Tsunemi, Miriam Harumi and Buchpiguel, Carlos Alberto and Caldas, Jose Guilherme Mendes Pereira},
title = {Cryoablation of bone metastases in thyroid and adrenocortical cancers},
journal = {Endocrine-Related Cancer},
year = {2026},
doi = {10.1530/erc-25-0306}
}
EUVIMED